Abstract: New World arenaviruses, which cause severe hemorrhagic fever, rely upon their envelope glycoproteins for attachment and fusion into their host cell. Here we present the crystal structure of the Machupo virus GP1 attachment glycoprotein which is responsible for high affinity binding at the cell-surface to the transferrin receptor. This first structure of an arenavirus glycoprotein shows that GP1 consists of a novel α/β-fold. This provides a blueprint of the New World arenaviruses attachment glycoproteins and reveals a new architecture of viral attachment, using a protein fold of unknown origins.
generally include fever, malaise and headaches, developing over seven to ten days into severe 7 hemorrhagic fever (13). The high fatality rate (~20%) and potential for global spread of this 8 rodent-borne virus by deliberate dissemination has resulted in its classification by the NIAID 9 as a high-priority Category A biothreat agent (6). 10 MACV is an ambi-sense RNA enveloped virus composed of a bi-segmented genome. 11
The L (large) segment encodes a RNA-dependent polymerase (L) and a zinc-finger matrix 12 protein (Z); the S (small) segment encodes the nucleoprotein (NP) and the viral glycoprotein 13 precursor GPC (9). The L and NP proteins are coded in the conventional sense for a negative 14 sense RNA virus whilst Z and GPC are transcribed from an anti-sense genome (Fig. 1) . GPC 15 is cleaved by the cellular proprotein convertase site 1 protease (39) to yield a stable complex 16 composed of a 58-amino-acid signal peptide which is necessary for virus infectivity, a GP1 17 subunit which is involved in receptor attachment (199 amino acids), and a transmembrane 18 bound GP2 subunit (249 amino acids) which is putatively classified as a class-I fusion protein 19 (23, 38) ( Fig. 1) . 20 MACV-GP1 maintains low sequence identity with the GP1s of other New World HF 21 arenaviruses (47, 27, 31, and 30% for JUNV, SABV, GTOV, and CAPV, respectively). 22
Nevertheless, recent studies have shown that the transferrin receptor (TfR1) is a cellular 23 receptor for the GP1 of MACV, JUNV, GTOV, and SABV (24, 35, 36) . These studies are an 24 on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from important step towards defining the viral tropism, and this interaction provides a target for the 1 development of antivirals and prophylactic vaccines to prevent New World arenavirus 2 infection. Knowledge of the molecular determinants of arenaviral attachment and fusion is a 3 prerequisite for the rational development of immunotherapeutic and antiviral reagents 4 (analogous to the development of neuraminidase inhibitors for the treatment of influenza (4)). 5
To this end, we have solved the structure of the MACV-GP1. 6
The globular domain of Machupo virus GP1 glycoprotein (MACV-GP1) responsible 7 for attachment to TfR1 (residues 87−257 from the complete mature GP1 which comprises 8 residues 59−257; GenBank accession number AAS77647.1; cDNA synthesized by Codon 9 Devices; Fig. 1 ) was cloned into the pHLsec vector containing the chicken RPTPσ signal 10 sequence (5). This region was selected based on the disorder predictions of RONN (44) and 11 consideration of potential disulphide bond patterns. MACV-GP1 was expressed in HEK 12 293T cells transfected with 2 mg DNA/L of cell culture in the presence of 5 µM kifunensine 13 which prevents glycosylation processing, resulting in protein bearing oligomannose-type 14 glycans (12). MACV-GP1 protein was purified from the cell supernatant using immobilized 15 metal-affinity followed by size exclusion chromatography (SEC) using a Superdex 200 10/30 16 column (Amersham) equilibrated in 150 mM NaCl and 10 mM Tris pH 8.0 ( Fig. 2A and B) . 17
Protein yields were ~2.0 mg MACV-GP1/L cell culture. The binding activity of MACV-GP1 18 to TfR1 (GenBank NC_BC001188, residues 122-760 cloned into the pHLSEC vector (5)) 19 was confirmed by co-expression and purification (as described above) of a MACV-20 GP1−TfR1 complex from GlcNAc Transferase I (GnTI)-deficient HEK 293S cells (37) ( remote' between platinum L1 and L2 edges). High resolution (1.7 Å) data were recorded 7 from a native crystal on ID14-EH1. Images were indexed, integrated and scaled using 8 HKL2000 (32). Data collection and crystallographic statistics are presented in Table 1 . 9
Phase determination used the Multiple Anomalous Dispersion (MAD) method. 10
Heavy atom positions were identified using SHELXD (40), initial phases were refined using 11 SHARP (20), solvent flattening was performed using SOLOMON (2) and DM (17), and the 12 resulting low resolution (4 Å) electron density map was used for initial model building of the 13 single molecule in the asymmetric unit (solvent content 50%). This initial model was placed 14 into the high resolution data using PHASER (30) and model building completed 15 automatically using ARP-wARP (33). Structure refinement iterated cycles of restrained 16 refinement with TLS using REFMAC5 (31) and manual rebuilding using COOT (22). The 17 final model was validated using MolProbity (19). 96.7% of residues lie within favored 18 regions of the Ramachandran plot and the remainder in additionally allowed regions (19). 19
Coordinates and structure factors have been deposited with the Protein Data Bank (PDB code 20 2WFO). 21
The 1.7 Å resolution structure of MACV-GP1 is shown in Fig. 3 . Although the 22 MACV-GP1 used for crystallization included residues 87−257 (Fig. 1) , we do not see 23 electron density for the last twenty C-terminal residues (the residues preceding the point of 24
on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from GP1/GP2 cleavage). MACV-GP1 appears to be monomeric in the crystal. Structural 1 database comparison (27, 45) suggests that MACV-GP1 is composed of a fold that has not 2 been previously observed. The N-and C-termini extend in the same direction and the 3 secondary structure consists of seven anti-parallel β-strands forming a left-handed sheet 4 (designated 1−7), three α-helices, one of which is preceded by a 3 10 helix, and two additional 5 3 10 helices ( Fig. 3A and B, and Fig. S1 in the supplemental material). When looking onto the 6 edge of the β-sheet, the overall fold appears to be similar to the shape of a positive meniscus 7 lens where the three large helices protect the convex side of the β-sheet whereas the concave 8 side of the β-sheet is largely uncovered ( Fig. 3B and D). The secondary structure is 9 stabilized by four disulfide bonds which are present around the plane of the lens (Fig. 3C) . 10
Two of these disulfide bonds appear to be conserved across the New World HF arenaviruses, 11 a third is also found in the GP1 of JUNV, whilst the fourth stabilizes a MACV-specific 12 insertion ( Fig. 3C−E) . The presence of an additional conserved disulphide bond between 13 MACV-GP1 and JUNV-GP1 reflects the close relationship between these two viruses with 14 respect to other New World arenaviruses (8, 11, 14), thus for the portion of the GP1 we have 15 analyzed, the sequence identity is 40% (Fig. 1E ) and we would therefore expect the two 16 structures to agree with approximately 1.2-Å r. m. s. deviation over matching Cα atoms (16). 17
Four N-linked glycosylation sites lie on the perimeter of the plane of the β-sheet ( Fig.  18 3C and D). Electron density was observed for at least the reducing terminal N-19 acetylglucosamine (GlcNAc) residue at each of these sites (Fig. 4) . B-factors for glycan 20 atoms (Table 1) are not significantly greater than those of other surface atoms. 21
Deglycosylation of MACV-GP1 with Endo F 1 resulted in precipitation (data not shown) 22
suggesting that, as reported for some other systems (34), glycans stabilize the protein. which bears further solvent-exposed aromatic residues). The glycan at Asn178 lies at the 3 center of a cavity on the protein surface, braced by a network of hydrogen bonds (Fig. 4C) , 4 including one to Glu184 which may stabilize the loop following the β6 strand. 5
Oligomannose structures are often observed on glycoproteins from enveloped viruses, for 6 example HIV-1, Dengue, and Ebola viruses (3, 18, 29, 41), where they can influence viral 7 tropism and stimulate the host immune response (28). Whilst glycosylation processing of 8 complex-type structures is influenced by tissue specific processing, oligomannose-type 9 glycans are frequently highly conserved between recombinant material and infectious virions. 10
For example, the oligomannose-type glycans of HIV-1 gp120 are also present in recombinant 11 gp120 monomers expressed in CHO cells (46). However, analysis of N-linked glycosylation 12 by MALDI-TOF mass spectrometry ( Fig. 4D and see Table S1 in the supplemental material) 13 demonstrated that recombinant MACV-GP1 contains instead highly branched, extensively 14 heterogeneous, complex-type glycans when expressed in the absence of any glycosidase 15
inhibitors. 16
Analyses of N-linked glycosylation sites across our GP1 segment from all New World 17 HF arenaviruses (MACV, JUNV, GTOV, SABV, and CAPV) reveals a total of 10 potential 18 sites which, when mapped onto the structure of MACV-GP1, decorate solvent-accessible 19 loops on the perimeter of the β-sheet (Fig. 5A) . Two sites are completely conserved, an 20 additional site is conserved between MACV and JUNV, and the majority of glycans cluster to 21 a specific side of the sheet (Fig. 5A) . In contrast, solvent accessible residues completely 22 conserved across the New World HF arenaviruses distribute in an almost complementary 23 pattern across the surface (Fig. 5B) . We suggest that the area containing the carbohydrate 24 on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from cluster is likely to be structurally variable amongst New World HF arenaviruses and that 1 surfaces involved in receptor binding and interaction with GP2 are likely to lie outside of this 2 region, perhaps focused on the regions of the surface containing the conserved residues (Fig.  3   5B) . 4
The crystal structure of the MACV-GP1 reported herein represents the first structure 5 of a New World arenavirus GP1. In agreement with previous phylogenetic studies (8, 11, 6 14), our structure-based analysis of conserved disulphide bonds and predicted N-linked 7 glycosylation suggests that MACV-GP1 is likely to have the greatest structural similarity to 8 the JUNV-GP1. More generally, given the conserved tropism of both pathogenic and non-9 
